Acadia Pharma News, Acadia Pharma Quote, ACAD Quote

Acadia Pharma (NQ:ACAD) Delayed: 16.59 -0.15 (0.9%)

Prev. Close

$16.74

Open

$16.81

52 Wk High

$42.49

52 Wk Low

$16.64

Day High

$16.86

Day Low

$16.55

P/E

N/A

EPS

$-0.42

Volume

1,296,887

Friends, Peers and Foes (?): ORCL, ONON, IBM, AAL, MMM (more...)

Apr 24, 2024 04:05 PM Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
Apr 22, 2024 09:04 AM Acadia Pharma (ACAD) Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Apr 22, 2024 09:04 AM Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Apr 19, 2024 04:05 PM Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 17, 2024 04:05 PM Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Apr 15, 2024 06:01 PM Form 3 ACADIA PHARMACEUTICALS For: Apr 04 Filed by: Thompson Elizabeth H.Z.
Apr 12, 2024 04:54 AM Acadia Pharmaceuticals (ACAD) PT Lowered to $26 at BofA Securities
Apr 9, 2024 06:01 PM Form 4 ACADIA PHARMACEUTICALS For: Apr 05 Filed by: DAVIS STEPHEN
Apr 9, 2024 06:01 PM Form 4 ACADIA PHARMACEUTICALS For: Apr 05 Filed by: Teehan Brendan
Apr 9, 2024 06:00 PM Form 4 ACADIA PHARMACEUTICALS For: Apr 05 Filed by: Kihara James

Entities mentioned with ACAD